
On a number of occasions, we have been told, “<em>Utna hi likhiye jitna mere Rs 7 a copy ki cost mein fit ho sakey</em>.” So, information is rationed, pages trimmed and printing cost stric...

The small-cap universe is a treasure trove of bargains— provided you can spot them. Money Today ties up with Trisys Research to identify stocks that aren’t in the limelight, but have the p...

The vigorous turnaround of the ferro alloys sector has highlighted the usual suspects. The unlikely underdog is clearly Maithan Alloys, a company that has been low on profile but high on achievement.

JRG Securities serves the bottom of India’s financial pyramid. What better place to start than Kerala, which is an extension of West Asia on the financial parameter and the developed West when y...

Zensar has projected sales of Rs 950 crore and net profits of Rs 80 crore for 2008-9 against an exchange rate of Rs 39 to a dollar. The dollar has now crossed Rs 42. It is an opportunity to be grabbed...

A growing portfolio of brands, expansion into more states and bigger orders from its MNC and Indian clients will ensure that Twilight Litaka Pharma’s revenues more than double to Rs 475 crore by...

At 80% of the company’s 40 MW capacity–expected to be fully commissioned by December 2008–the company can potentially generate more than Rs 500 crore in annual revenues.

Sirpur Paper will produce a higher quantity of pulp and paper at almost identical overheads, enabling it to cover its fixed costs more effectively. Besides, it will now be in a position to export its ...

Sagar’s fully diluted equity will be no more than Rs 14 crore after the 2.5 million TPA have gone on stream at the end of the first quarter of 2008-9. Perhaps it is this equity-capacity ratio th...

<p>Following the benefits from the new Uttaranchal plant in 2008-9, Riddhi Siddhi Gluco Biols may report an EBITDA higher than Rs 100 crore for the coming financial year on a market capitalisation les...





